
    
      OBJECTIVE: This study aimed to evaluate the efficacy of high-frequency rTMS over left
      dorsolateral prefrontal cortex in the treatment of symptoms and cognitive functioning in 200
      chronic patients with schizophrenia and 200 patients with major depressive disorders

      METHODS:

        1. Clinical Trialï¼šThe study consists of 4 weeks of treatment.

        2. Assess Procedures:

      2.1 Primary Outcome Variable-Psychopathology: The psychopathology of patients was assessed by
      three clinical trained staff, who were blind to treatment protocols, using the Positive and
      Negative Syndrome Scale (PANSS) or DSM-IV for depression, and repeatable battery for the
      assessment of neuropsychological status(RBANS).Patients are interviewed at screening, at at
      baseline, 4 weeks, 16 weeks.

      2.2 Side effects: The side effect rating scale (UKU) was used to assess the side effect at
      baseline, 4 weeks, and 16 weeks.

      2.3 Weight gain measurement: weight gain every week
    
  